Avantor, Inc. (AVTR)
15.34
+0.31
(+2.06%)
USD |
NYSE |
Oct 02, 16:00
15.34
0.00 (0.00%)
Pre-Market: 20:00
Avantor Market Cap : 10.38B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.38B |
| October 01, 2026 | 10.17B |
| September 30, 2026 | 10.18B |
| September 29, 2026 | 10.31B |
| September 28, 2026 | 10.34B |
| September 25, 2026 | 10.32B |
| September 24, 2026 | 10.40B |
| September 23, 2026 | 9.985B |
| September 22, 2026 | 10.11B |
| September 21, 2026 | 10.22B |
| September 18, 2026 | 10.50B |
| September 17, 2026 | 10.73B |
| September 16, 2026 | 10.56B |
| September 15, 2026 | 10.45B |
| September 14, 2026 | 10.26B |
| September 11, 2026 | 10.02B |
| September 10, 2026 | 10.07B |
| September 09, 2026 | 10.07B |
| September 08, 2026 | 10.32B |
| September 04, 2026 | 10.13B |
| September 03, 2026 | 10.28B |
| September 02, 2026 | 9.911B |
| September 01, 2026 | 9.606B |
| August 31, 2026 | 9.836B |
| August 28, 2026 | 9.863B |
| Date | Value |
|---|---|
| August 27, 2026 | 9.884B |
| August 26, 2026 | 9.809B |
| August 25, 2026 | 9.755B |
| August 24, 2026 | 9.647B |
| August 21, 2026 | 9.782B |
| August 20, 2026 | 9.640B |
| August 19, 2026 | 9.444B |
| August 18, 2026 | 9.018B |
| August 17, 2026 | 9.133B |
| August 14, 2026 | 9.241B |
| August 13, 2026 | 9.370B |
| August 12, 2026 | 9.424B |
| August 11, 2026 | 9.315B |
| August 10, 2026 | 9.288B |
| August 07, 2026 | 9.194B |
| August 06, 2026 | 8.916B |
| August 05, 2026 | 9.038B |
| August 04, 2026 | 9.255B |
| August 03, 2026 | 9.248B |
| July 31, 2026 | 9.322B |
| July 30, 2026 | 9.376B |
| July 29, 2026 | 9.728B |
| July 28, 2026 | 8.402B |
| July 27, 2026 | 7.956B |
| July 24, 2026 | 7.739B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Medpace Holdings, Inc. | 16.69B |
| Champions Oncology, Inc. | 68.76M |
| Personalis, Inc. | 1.732B |
| Adaptive Biotechnologies Corp. | 4.509B |
| 10X Genomics, Inc. | 12.18B |
Market Cap Related Metrics
| PS Ratio | 1.587 |
| Price to Book Value | 1.843 |
| Price to Free Cash Flow | 22.90 |
| Price | 15.34 |
| Earnings Yield | -5.52% |
| Operating PE Ratio | 19.35 |
| Normalized PE Ratio | 1826.19 |